As on Wednesday, MBX Biosciences Inc (NASDAQ: MBX) got off with the flyer as it spiked 1.61% to $13.28, before settling in for the price of $13.07 at the close. Taking a more long-term approach, MBX posted a 52-week range of $4.81-$27.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Nevertheless, stock’s Earnings Per Share (EPS) this year is 52.89%. This publicly-traded company’s shares outstanding now amounts to $33.42 million, simultaneously with a float of $14.84 million. The organization now has a market capitalization sitting at $443.88 million. At the time of writing, stock’s 50-day Moving Average stood at $11.51, while the 200-day Moving Average is $14.46.
MBX Biosciences Inc (MBX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. MBX Biosciences Inc’s current insider ownership accounts for 55.59%, in contrast to 54.40% institutional ownership. According to the most recent insider trade that took place on Apr 08 ’25, this organization’s Director bought 7,693 shares at the rate of 5.89, making the entire transaction reach 45,312 in total value, affecting insider ownership by 24,329. Preceding that transaction, on Feb 18 ’25, Company’s Director bought 143,170 for 10.84, making the whole transaction’s value amount to 1,551,963. This particular insider is now the holder of 3,255,000 in total.
MBX Biosciences Inc (MBX) Earnings and Revenue Records
MBX Biosciences Inc’s EPS increase for this current 12-month fiscal period is 52.89% and is forecasted to reach -2.68 in the upcoming year.
MBX Biosciences Inc (NASDAQ: MBX) Trading Performance Indicators
Let’s observe the current performance indicators for MBX Biosciences Inc (MBX). It’s Quick Ratio in the last reported quarter now stands at 23.31.
In the same vein, MBX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.20, a figure that is expected to reach -0.75 in the next quarter, and analysts are predicting that it will be -2.68 at the market close of one year from today.
Technical Analysis of MBX Biosciences Inc (MBX)
Through scrutinizing the latest numbers posted by the [MBX Biosciences Inc, MBX], it can be observed that its last 5-days Average volume of 0.35 million was better the volume of 0.3 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 89.63% While, its Average True Range was 71.09%.
Raw Stochastic average of MBX Biosciences Inc (MBX) in the period of the previous 100 days is set at 88.93%, which indicates a major rise in contrast to 82.26% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.11 that was higher than 1.00 volatility it exhibited in the past 100-days period.
